Document is current
Any future updates will be listed below
-
Authors
Barbanti, Piero
Tassorelli, Cristina
Vernieri, Fabrizio https://orcid.org/0000-0002-9594-9336
De Cesaris, Francesco
De Icco, Roberto
Di Lorenzo, Cherubino
Finocchi, Cinzia
Grazzi, Licia
Guerzoni, Simona
Mampreso, Edoardo
Mastronuzzi, Tecla
Messina, Roberta
Ornello, Raffaele
Rao, Renata
Taddeo, Daiana
De Tommaso, Marina
Rainero, Innocenzo
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 5 February 2026
Accepted: 30 April 2026
First Online: 19 May 2026
Declarations
:
: N/A.
: N/A.
: PB: travel grants, honoraria for advisory boards, speaker panels or clinical investigation studies from AbbVie, Alder, Amgen, Angelini, Assosalute, Bayer, Biohaven, DOC Pharma, Eli-Lilly, Fondazione Ricerca e Salute, GSK, Lundbeck, Lusofarmaco, Noema Pharma, Novartis, Organon, Orion Pharma, Pfizer, Teva, Viatris, Visufarma, Zambon and serves as President with Italian Association of Headache Sufferers.FDC: participation as an invited speaker or panelist at meetings supported by AbbVie, Organon, and Teva.CDL: participation in advisory boards and giving presentations with support from Pfizer and Teva. CF: support from Teva, Pfizer, AbbVie, Organon, Orion, and Lilly.SG: travel grants and honoraria from Organon, Lundbeck, Teva, Pfizer, AbbVie.EM: speaker honoraria and advisory board participation from Abbvie, Lundbeck, Eli-Lilly, Organon, Pfizer, Teva.RM: personal fees from AbbVie, Biomedia, Lundbeck, Organon, Pfizer, and Teva, and grants from the Italian Ministry of Health, outside of the submitted work.RO: personal fees from AbbVie, Bayer, Eli Lilly, Lundbeck, Novartis, Organon, Pfizer, Teva.RR: participation in advisory boards, speaker panels, and congress-related activities for Lundbeck, Pfizer, Organon, AbbVie, and Teva.FV: financial support from Allergan-AbbVie, Angelini and Lundbeck for investigator-initiated trials; consulting fees for the participation in advisory boards from AbbVie, Angelini, Eli Lilly, Lundbeck, Organon, Novartis, Pfizer, and Teva; honoraria for scientific lectures and presentations from AbbVie, Eli Lilly, Lundbeck, Novartis, Organon, Pfizer, and Teva; support for attending meetings from AbbVie, Amgen, Eli Lilly, Lundbeck, Pfizer, and Teva; he has been Principal Investigator in clinical trials sponsored by AbbVie, Eli Lilly, Lundbeck, Pfizer, and Teva; he is Co-Specialty Editor for Frontiers in Neurology Headache and Neurogenic Pain section.RDI, MDT, LG, TM, IR, DT, CT: nothing to declare.
